Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

GlaxoSmithKline Q1 Net Profit Down, Core EPS Up - Quick Facts

RELATED NEWS
Trade GSK now with 

GlaxoSmithKline plc (GSK.L,GSK: Quote) reported a drop in first-quarter profit attributable to shareholders to 1.325 billion pounds from 1.525 billion pounds last year, with earnings per share falling to 26.3 pence from 29.6 pence a year ago.

However, core earnings per share for the recent quarter were 27.3 pence, higher than the prior-year quarter's 25.9 pence, up 7% in CER terms and 5% in sterling terms reflecting the strengthening of Sterling against the Euro and higher exchange losses on settled inter-company transactions, partly offset by the weakness of Sterling against the US Dollar and Japanese Yen.

Group turnover for the quarter went up 2% to 6.64 billion pounds from 6.585 billion pounds in the comparable period. In addition, the board has declared a first interim dividend of 17 pence per share. The company's 2012 outlook for sales growth and gradual expansion of core margin remained unchanged.

Click here to receive FREE breaking news email alerts for GlaxoSmithKline PLC and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.